Notable Achievements

2015-2023

Seven-Fold Revenue Growth in Biotech Operations

Under Michael's operational leadership, Mircod Biotech Group achieved a 7x revenue increase over a 24-month period, scaling from $1M to $7M through manufacturing optimization, strategic partnerships, and regulatory compliance excellence.

Biotech Manufacturing Growth
2015 - 2023

ISO 13485 Certification Achieved for Medical Device Manufacturing

Successfully led the buildout and certification of ISO 13485-compliant manufacturing facilities supporting production of cell therapy tools, bioreactors, and diagnostic devices for global markets.

MedTech Compliance Quality Systems
2022

Patent Portfolio Expansion in Medical Technology

Contributed to filing and prosecution of 15+ patents in medical device technology, covering innovations in cell therapy systems, bioreactor design, and diagnostic instrumentation.

IP Innovation MedTech

Company Milestones

2013-2015

Luma Strike Inc.: Data-Driven Product Development

As Chief Engineer and Co-Founder, built engineering pipelines that increased development efficiency by 30%, while overseeing product strategy and market growth initiatives.

Engineering Product Efficiency
2011

Finaro (CredoRax) Exit: Building Global Payment Infrastructure

Founded and served as CTO, architecting payment systems that scaled to 2M+ monthly transactions. Successfully raised $15M in venture capital and achieved acquisition, expanding platform across USA, Israel, EU, China, and Japan.

FinTech Exit M&A

Industry Recognition

ONGOING

Patents & Intellectual Property

View Michael's complete patent portfolio on Justia Patents, covering innovations in medical devices, bioreactor systems, and therapeutic technologies.

View Patent Portfolio
ONGOING

Medical Device Demonstrations

Video demonstrations of medical devices and systems developed under Michael's engineering and operational leadership, showcasing innovation in biotech and MedTech.

Watch Device Demo

Media Inquiries

For press inquiries, speaking engagements, or media requests, please contact: